These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5954578)
1. Absorption of thyroid-stimulating globulin from thyrotoxic sera by organ homogenates. el Kabir DJ; Benhamou-Glynn N; Doniach D; Roitt IM Nature; 1966 Apr; 210(5033):319-21. PubMed ID: 5954578 [No Abstract] [Full Text] [Related]
2. On incubation of long acting thyroid stimulator with human thyroid and adrenal homogenates. Dandona P; El Kabir DJ Clin Endocrinol (Oxf); 1980 Apr; 12(4):379-83. PubMed ID: 6247108 [TBL] [Abstract][Full Text] [Related]
3. Absorption of the long-acting thyroid stimulator by human thyroid microsomes. Dorrington KJ; Carneiro L; Munro DS J Endocrinol; 1966 Jan; 34(1):133-4. PubMed ID: 5900575 [No Abstract] [Full Text] [Related]
4. The interaction between LATS and thyroid tissue in vitro. Smith BR; Munro DS Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011 [No Abstract] [Full Text] [Related]
5. The interaction between thyroid tissue and the long-acting thyroid stimulator. Kendall-Taylor P; Smith BR; Munro DS Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160 [No Abstract] [Full Text] [Related]
6. Evidence that mouse thyroid stimulator does not stimulate the human thyroid gland. Adams DD; Kennedy TH; Stewart RD Aust N Z J Med; 1976 Aug; 6(4):300-4. PubMed ID: 1070985 [TBL] [Abstract][Full Text] [Related]
8. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. Mori T; Fisher J; Kriss JP J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195 [No Abstract] [Full Text] [Related]
9. Studies on the binding activity for the long-acting thyroid stimulator. Dirmikis S; Munro DS J Endocrinol; 1973 Sep; 58(3):577-90. PubMed ID: 4743535 [No Abstract] [Full Text] [Related]
10. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. McKenzie JM; Zakarija M J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449 [TBL] [Abstract][Full Text] [Related]
11. Discrepancy between inactivation by thyroid particulate fraction and thyroid stimulating activity of long-acting thyroid stimulator (LATS). Shishiba Y; Shimizu T; Yoshimura S; Shizume K J Clin Endocrinol Metab; 1972 Jan; 34(1):7-12. PubMed ID: 5061777 [No Abstract] [Full Text] [Related]
12. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro. Wong ET; Litman GW J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323 [No Abstract] [Full Text] [Related]
13. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis. Adams DD; Kennedy TH; Stewart RD Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686 [TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on hyperthyroidism with special references to clinical-statistical surveys and studies on 131-I-triiodothyronine resin sponge uptake test and long-acting thyroid stimulator (LATS)]. Hayashida M Sapporo Igaku Zasshi; 1966 Dec; 30(6):292-320. PubMed ID: 6010790 [No Abstract] [Full Text] [Related]
20. [Status of the histaminergic system of the thyroid gland in thyrotoxic patients]. Rom-Bugoslavskaia ES; Brindak OI; Tsarikovskaia NG Fiziol Zh (1978); 1985; 31(6):746-9. PubMed ID: 4076464 [No Abstract] [Full Text] [Related] [Next] [New Search]